⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 11, 2018Diabetes Obesity and MetabolismOpen Access

Safety and efficacy of once‐weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial

Kohei Kaku Yuichiro Yamada Hirotaka Watada Atsuko Abiko Tomoyuki Nishida Jeppe Zacho Arihiro Kiyosue

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Semaglutide was well tolerated, with no new safety issues identified. Semaglutide treatment significantly reduced HbA1c and body weight vs additional OAD treatment in Japanese people with T2D.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kaku et al. (2018) studied this question.

synapsesocial.com/papers/69dc9fcf89c4deb67d3593e3 https://doi.org/10.1111/dom.13218

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Trends in the prevalence of type 2 diabetes and prediabetes in community‐dwelling Japanese subjects: The Hisayama StudyOriginal Research · 2013 · 52 citations
2The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus1993 · 24,789 citations
3The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010Cross-Sectional Study · 2013 · 718 citations
4Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of DiabetesClinical Guideline · 2014 · 3,084 citations
5GLP-1 receptor agonists: a review of head-to-head clinical studiesHuman Clinical Trial · 2014 · 284 citations
6Semaglutide, a once‐weekly human GLP‐1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrelOriginal Research · 2014 · 183 citations
7Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide2015 · 1,113 citations
8Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesRandomized Controlled Trial · 2016 · 7,115 citations
9Differences in the Glucose Management Indicator Between Continuous Glucose Monitoring SystemsDiabetes Obesity and Metabolism · 2026
10Association Between Weight Loss on Incretin‐Based Therapy and Cardiovascular Outcomes and Mortality: A Systematic Review and Meta‐RegressionDiabetes Obesity and Metabolism · 2026

More from Diabetes Obesity and Metabolism

More from Juntendo University

More from Akita University

More from Kawasaki Medical School

More from Asahikawa Medical University

More from Minamiaoyama Eye Clinic